Device Therasphere Administration Set_pi

Therasphere Administration Set

Payments companies reported to CMS as associated with Therasphere Administration Set. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$153Kassociated payments (2023-2025)
676clinicians with associated payments
1company reporting

By year

2023 $11K
2024 $65K
2025 $78K

Payments reported as associated with Therasphere Administration Set, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $88K
Diagnostic Radiology $18K
Gastroenterology (Internal Medicine) $7,935
Hepatology $7,200
Medical Oncology $6,829
Surgery $3,260

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Therasphere Administration Set

These are the largest totals companies reported as associated with Therasphere Administration Set. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Tyler Sandow New Orleans, LA Vascular & Interventional Radiology $15,100.10
Juan Gimenez New Orleans, LA Vascular & Interventional Radiology $14,706.05
Amit Singal Dallas, TX Hepatology $7,200.00
Anjana Pillai Cleveland, OH Gastroenterology (Internal Medicine) $7,150.00
William Rilling Milwaukee, WI Vascular & Interventional Radiology $6,436.68
Ben George Rochester, MN Medical Oncology $6,250.00
Nima Kokabi Atlanta, GA Vascular & Interventional Radiology $5,156.72
Mikin Patel Chicago, IL Diagnostic Radiology $4,379.15
Shamar Young Tucson, AZ Vascular & Interventional Radiology $4,200.00
Paul Gulotta New Orleans, LA Neuroradiology $1,624.02

Prescribed Therasphere Administration Set?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.